Xlife Sciences AG (SWX:XLS)
Switzerland · Delayed Price · Currency is CHF 21.10
+0.10 (0.48%)
Last updated: Aug 21, 2025
Xlife Sciences AG Income Statement
Financials in millions CHF. Fiscal year is January - December.
Millions CHF. Fiscal year is Jan - Dec.
Fiscal Year | FY 2024 | FY 2023 | FY 2022 | FY 2021 | FY 2020 | 2019 |
|---|---|---|---|---|---|---|
Period Ending | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 | Dec '20 Dec 31, 2020 | 2019 |
| 0.83 | 0.99 | 1.03 | 0.81 | 0.4 | Upgrade | |
Revenue Growth (YoY) | -15.53% | -3.85% | 27.53% | 103.14% | -22.93% | Upgrade |
Cost of Revenue | 0.29 | 0.54 | 0.84 | 0.45 | 0.42 | Upgrade |
Gross Profit | 0.55 | 0.45 | 0.19 | 0.36 | -0.03 | Upgrade |
Selling, General & Admin | 4.1 | 4.75 | 5.2 | 5.53 | 2.96 | Upgrade |
Other Operating Expenses | -0.26 | -0.02 | -0.05 | -0 | 0.04 | Upgrade |
Operating Expenses | 19.9 | 20.75 | 21.17 | 5.59 | 3.07 | Upgrade |
Operating Income | -19.35 | -20.31 | -20.98 | -5.23 | -3.09 | Upgrade |
Interest Expense | -0.47 | -0.39 | -0.69 | -0.5 | -0.18 | Upgrade |
Interest & Investment Income | 0.38 | 0.03 | 0.21 | 0.1 | 0 | Upgrade |
Earnings From Equity Investments | -13.23 | -7.8 | -9.02 | -0.97 | 0.17 | Upgrade |
Currency Exchange Gain (Loss) | 0.06 | -0.74 | -0.24 | -0.13 | -0.01 | Upgrade |
Other Non Operating Income (Expenses) | 0 | - | -0 | 0 | 0 | Upgrade |
EBT Excluding Unusual Items | -32.62 | -29.21 | -30.72 | -6.73 | -3.12 | Upgrade |
Gain (Loss) on Sale of Investments | 56.54 | 15.88 | 34.76 | -18.12 | 24.31 | Upgrade |
Asset Writedown | 0 | -0 | -0 | - | - | Upgrade |
Other Unusual Items | 0.04 | 17.87 | - | 78.05 | - | Upgrade |
Pretax Income | 23.97 | 4.53 | 4.04 | 53.19 | 21.2 | Upgrade |
Income Tax Expense | -4.74 | -4.74 | -4.74 | -0.08 | 0.09 | Upgrade |
Earnings From Continuing Operations | 28.71 | 9.27 | 8.78 | 53.28 | 21.1 | Upgrade |
Minority Interest in Earnings | 5.57 | 5.61 | 5.53 | 0.14 | 0.36 | Upgrade |
Net Income | 34.28 | 14.88 | 14.31 | 53.42 | 21.46 | Upgrade |
Net Income to Common | 34.28 | 14.88 | 14.31 | 53.42 | 21.46 | Upgrade |
Net Income Growth | 130.37% | 3.96% | -73.21% | 148.91% | 1943.57% | Upgrade |
Shares Outstanding (Basic) | 6 | 5 | 5 | 5 | 4 | Upgrade |
Shares Outstanding (Diluted) | 7 | 7 | 7 | 6 | 6 | Upgrade |
Shares Change (YoY) | 1.34% | -0.17% | 17.26% | 4.77% | 60.85% | Upgrade |
EPS (Basic) | 6.00 | 2.73 | 2.72 | 11.30 | 5.62 | Upgrade |
EPS (Diluted) | 4.54 | 2.08 | 2.00 | 8.66 | 3.66 | Upgrade |
EPS Growth | 118.26% | 4.15% | -76.95% | 136.46% | 1184.65% | Upgrade |
Free Cash Flow | -0.43 | 0.16 | -4.62 | -4.48 | -0.43 | Upgrade |
Free Cash Flow Per Share | -0.06 | 0.02 | -0.64 | -0.72 | -0.07 | Upgrade |
Gross Margin | 65.82% | 45.43% | 18.06% | 44.55% | -6.45% | Upgrade |
Operating Margin | -2317.30% | -2054.30% | -2041.02% | -649.21% | -779.56% | Upgrade |
Profit Margin | 4105.62% | 1505.34% | 1392.26% | 6627.06% | 5408.47% | Upgrade |
Free Cash Flow Margin | -51.94% | 15.97% | -449.70% | -555.75% | -108.75% | Upgrade |
EBITDA | -3.39 | -4.38 | -5.07 | -5.2 | -3.09 | Upgrade |
D&A For EBITDA | 15.96 | 15.92 | 15.91 | 0.03 | 0.01 | Upgrade |
EBIT | -19.35 | -20.31 | -20.98 | -5.23 | -3.09 | Upgrade |
Effective Tax Rate | - | - | - | - | 0.45% | Upgrade |
Updated Sep 18, 2024. Source: S&P Global Market Intelligence. Standard template. Financial Sources.